Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae
about
Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent modelsPlant-produced candidate countermeasures against emerging and reemerging infections and bioterror agentsPorifera Lectins: Diversity, Physiological Roles and Biotechnological PotentialBulk production of the antiviral lectin griffithsinMonomerization of Viral Entry Inhibitor Griffithsin Elucidates the Relationship between Multivalent Binding to Carbohydrates and anti-HIV ActivityGriffithsin: An Antiviral Lectin with Outstanding Therapeutic PotentialHIV-1 gp120 as a therapeutic target: navigating a moving labyrinthPharmacokinetics of the Antiviral Lectin Griffithsin Administered by Different Routes Indicates Multiple Potential UsesInvestigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidatePathogenesis and Inhibition of Flaviviruses from a Carbohydrate PerspectiveA novel and fully scalable Agrobacterium spray-based process for manufacturing cellulases and other cost-sensitive proteins in plants.High mannose-binding lectin with preference for the cluster of alpha1-2-mannose from the green alga Boodlea coacta is a potent entry inhibitor of HIV-1 and influenza viruses.Algal lectins as potential HIV microbicide candidatesInhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin.Griffithsin has antiviral activity against hepatitis C virusGriffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virusImproving the large scale purification of the HIV microbicide, griffithsin.Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice.Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competenceGriffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.Hepatitis C Virus Resistance to Carbohydrate-Binding AgentsDevelopment of novel entry inhibitors targeting emerging viruses.Griffithsin protects mice from genital herpes by preventing cell-to-cell spreadRice endosperm is cost-effective for the production of recombinant griffithsin with potent activity against HIV.The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism.Non-Antiretroviral Microbicides for HIV Prevention.Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses.Viral membranes: an emerging antiviral target for enveloped viruses?Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future PerspectivesAntiviral drug discovery: broad-spectrum drugs from nature.High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120.Human lectins and their roles in viral infections.Marine lectins and their medicinal applications.Antiviral lectins: Selective inhibitors of viral entry.Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo.Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapyHigh-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120.Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections.
P2860
Q24610025-ED57C8C8-C329-482C-B8FA-47F42839459DQ26783107-EA04803B-C1AA-4631-9AAD-880E65991430Q26799322-F45D86D7-B751-4520-A644-2389DF9FAEF4Q26801491-1A87F964-0740-4EFE-9A60-27C3BCFF8411Q27664363-53FAC08D-7FE8-48E5-B199-5ABAA72AE005Q27928014-8FB34EC7-F2C8-48FF-9804-A7F62E00B46AQ28086826-4FEE1C88-B548-4220-8690-372383C1B17AQ28354743-5AB88E8F-3FF2-4AC2-AA12-601E724316B9Q28741890-A69B5BD7-A0CD-4BE4-AD7C-2C865DEF7FDCQ29994529-1A87E2E8-601F-493B-800F-9A1FDA445463Q30316917-E43B3BD7-0995-424A-A99F-3F9B18B035FCQ30401412-B91F31EE-CEFA-4A4F-A5D9-66C1ED3E545EQ34291727-33D24597-4DED-46DC-8E11-D2C5E3647D9FQ34894092-9F4DA1F7-9D3D-4FF9-A764-989DC24781E9Q35363633-1A0A1C8A-D84F-4F2E-AF51-80A6BD2B24D4Q35568986-F5336FDD-138B-4E90-A061-2A677F694CF8Q35607915-918A9D62-929D-46DB-B9DC-EC1381CD254AQ35746244-34EF6FC3-FB69-4921-939B-69A3A55F2990Q35943657-CA79378C-1EF7-4875-9B7B-1152780BC50FQ36290533-82278101-BE19-4A95-A550-77D36A1063C5Q36327928-33CBBBF2-DCBB-4235-8F1A-99F4B6F6ED51Q36576382-80945D5C-8140-4672-9518-A58FBE0DDEBDQ36655280-B545E787-FFA9-4C89-AA0E-3F5822B53369Q36827173-D1B8DE7D-AC73-4058-8AFB-5E3C71A7FF64Q36896705-21DA25BA-AC88-43AA-8DEE-4F5595DD6EEAQ37036454-8AA162F5-9FAA-4B82-A37E-6DC277444E66Q37317845-3AD9DD7E-0484-4714-81D9-0EA068832E42Q37358616-AA29076E-176C-4FB5-840F-4528F370D7A8Q37450191-F18F11E2-2D74-4B0F-8D02-3F33F5D237D9Q37762540-D2C9ABCD-2873-4914-A88F-0C6567F3AC93Q38156667-439C39C0-7450-4239-81C1-7FB9CD82CF8CQ38260235-5072741E-DE5A-4594-A667-F33C1B29A558Q38294806-12A08E20-A841-4979-93F9-3C5DF202C2BDQ38340871-46592025-BEC5-4611-A98C-C3A6AF737E92Q38385723-881C04E2-2937-49CF-8395-A48CF9141277Q38891044-A149F416-5591-49DC-AD50-EA0C6AE58451Q39262442-204E3E52-68F0-4E62-A827-1D182404ACABQ39727842-2B1C330F-FF6F-48B8-ABBB-0AF16708D74EQ41107113-385DF9B4-3AC2-4143-96E1-EEE16F513A60Q47384815-05EDCA54-0D94-42B0-976A-BDB8628C6178
P2860
Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Broad-spectrum in vitro activi ...... es of the family Coronaviridae
@ast
Broad-spectrum in vitro activi ...... es of the family Coronaviridae
@en
Broad-spectrum in vitro activi ...... es of the family Coronaviridae
@nl
type
label
Broad-spectrum in vitro activi ...... es of the family Coronaviridae
@ast
Broad-spectrum in vitro activi ...... es of the family Coronaviridae
@en
Broad-spectrum in vitro activi ...... es of the family Coronaviridae
@nl
prefLabel
Broad-spectrum in vitro activi ...... es of the family Coronaviridae
@ast
Broad-spectrum in vitro activi ...... es of the family Coronaviridae
@en
Broad-spectrum in vitro activi ...... es of the family Coronaviridae
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Broad-spectrum in vitro activi ...... es of the family Coronaviridae
@en
P2093
Barbara Giomarelli
Barry R O'Keefe
Brian W Barnett
Christine L Wohlford-Lenane
Dale L Barnard
James B McMahon
Paul K S Chan
Shilpa R Shenoy
P2860
P304
P3181
P356
10.1128/JVI.02322-09
P407
P577
2010-03-01T00:00:00Z